Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€39.74

€39.74

1.650%
0.64
1.650%
€52.50
 
26.04.24 / Tradegate WKN: A3ENQ5 / Name: Schott Pharma & Co. Kgaa / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Schott Pharma AG & Co. Kgaa Stock

Schott Pharma AG & Co. Kgaa gained 1.650% today.
Our community is currently high on Schott Pharma AG & Co. Kgaa with 3 Buy predictions and 0 Sell predictions.
With a target price of 52 € there is a positive potential of 30.85% for Schott Pharma AG & Co. Kgaa compared to the current price of 39.74 €.

Pros and Cons of Schott Pharma AG & Co. Kgaa in the next few years

Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda
EQS-News: SCHOTT Pharma reports good start into fiscal year 2024
EQS-News: SCHOTT Pharma reports good start into fiscal year 2024
EQS-News: SCHOTT Pharma reports good start into fiscal year 2024